SCHEMBL7923573

SCHEMBL7923573

CC(C)(C)[N+]([O-])=Cc1ccc(F)cc1F

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 4/20 0.42
ATM Q13315 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
GRIN2D O15399 2/20 0.38
GRIN3B O60391 2/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
GRIN2B Q13224 2/20 0.38
GRIN2C Q14957 2/20 0.38
GRIN3A Q8TCU5 2/20 0.38
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
KCNH2 Q12809 1/20 0.35
HSPB1 P04792 1/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7922778 0.86 NFE2L2 (0.42) NFE2L2ATMTDP1
SCHEMBL8441698 0.83 NFE2L2 (0.35) NFE2L2ATMTDP1PTGS1PTGS2
SCHEMBL7921446 0.83 ALDH1A1 (0.36) HTR2AHTR2CKCNH2
SCHEMBL7914607 0.82 PTGS1 (0.37) NFE2L2ATMTDP1PTGS1PTGS2
SCHEMBL7923555 0.81 GAA (0.38) KCNH2CYP1A1CYP1B1
SCHEMBL7920975 0.81 ALDH1A1 (0.43) KCNH2
SCHEMBL7922797 0.80 HTR2A (0.39) NFE2L2HTR2AHTR2CKCNH2CYP1A1
SCHEMBL7921534 0.80 CYP1A1 (0.49) NFE2L2CYP1A1CYP1B1
SCHEMBL7914568 0.79 NFE2L2 (0.32) NFE2L2PTGS1PTGS2
SCHEMBL15216528 0.78 NFE2L2 (0.45) NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194461-B1 USEFUL AS MEDICAMENT FOR TREATING RETINAL DEGENERATIVE DISORDERS; ALPHA-(2,4-DIFLUOROPHENYL)-N-T-BUTYLNITRONE, AND CORRESPONDING AMINES WHICH WOULD BE CONVERTED IN VIVO TO THE NITRONE, FOR EXAMPLE SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-02-27 US disclosed
EP-0945426-A1 NITRONE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-09-29 EP disclosed